XML 30 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements Of Earnings - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0.0 0.0 0.0
Net sales $ 11,325 $ 9,946 $ 9,675
Cost of sales 3,830 3,344 3,319
Gross profit 7,495 6,602 6,356
Research, development and engineering expenses 715 625 614
Selling, general and administrative expenses 4,137 3,610 3,547
Recall charges, net of insurance proceeds 158 296 761
Amortization of intangible assets 319 210 188
Total operating expenses 5,329 4,741 5,110
Operating income 2,166 1,861 1,246
Other income (expense), net (245) (126) (86)
Earnings before income taxes 1,921 1,735 1,160
Income taxes 274 296 645
Net earnings $ 1,647 $ 1,439 $ 515
Net earnings per share of common stock:      
Basic net earnings per share of common stock (in dollars per share) $ 4.40 $ 3.82 $ 1.36
Diluted net earnings per share of common stock (in dollars per share) $ 4.35 $ 3.78 $ 1.34
Weighted-average shares outstanding:      
Basic (in shares) 374.1 376.6 378.5
Net effect of dilutive employee stock options (in shares) 4.4 4.3 4.3
Diluted (in shares) 378.5 380.9 382.8